Lipid nanoparticles: A challenging approach for oral delivery of BCS Class-II drugs
In today's drug development world, combinatorial chemistry, high-throughput screening, and genomics have provided a technologic platform that produces a large number of new chemical entities with therapeutic potential each year. Its outcome the new chemical entities shifted towards higher molec...
Main Authors: | Ganesan Poovi, Narayanasamy Damodharan |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2018-12-01
|
Series: | Future Journal of Pharmaceutical Sciences |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2314724517301656 |
Similar Items
-
Development of a BCS Class II Drug Microemulsion for Oral Delivery: Design, Optimization, and Evaluation
by: Marwa Tlijani, et al.
Published: (2021-01-01) -
Effects of PEGylated lipid nanoparticles on the oral absorption of one BCS II drug: a mechanistic investigation
by: Zhang XW, et al.
Published: (2014-11-01) -
Enhancing the bioavailability of BCS Class IV drugs using polymeric nanoparticles
by: Soundararajan, R.
Published: (2016) -
Lipid Based Formulations of Biopharmaceutics Classification System (BCS) Class II Drugs: Strategy, Formulations, Methods and Saturation
by: Šoltýsová I., et al.
Published: (2016-12-01) -
DISSOLUTION PROFILE STUDIES OF BCS CLASS II DRUG VALSARTAN BY BIOWAIVER PROCEDURE
by: E. R. Brigas, et al.
Published: (2019-01-01)